Search

Your search keyword '"Alain Hendlisz"' showing total 131 results

Search Constraints

Start Over You searched for: Author "Alain Hendlisz" Remove constraint Author: "Alain Hendlisz" Search Limiters Full Text Remove constraint Search Limiters: Full Text
131 results on '"Alain Hendlisz"'

Search Results

1. PD-L1 Expression in Paired Samples of Rectal Cancer

2. Development of Clinical Radiomics-Based Models to Predict Survival Outcome in Pancreatic Ductal Adenocarcinoma: A Multicenter Retrospective Study

3. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers

4. Prognostic Value of Circulating Cytokines in Chemorefractory Colorectal Cancer

5. Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study

6. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients

7. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

8. The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases

9. Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report

10. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

11. Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance

12. Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma

13. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

14. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

15. Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer

16. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

17. 90Y-PET/CT-based dosimetry after selective internal radiation therapy predicts outcome in patients with liver metastases from colorectal cancer

18. FOLFIRI as second-line treatment of metastatic biliary tract cancer patients

19. Differentiated-Type Intraepithelial Neoplasia-Like Lesion Associated with Squamous Cell Carcinoma of the Anus: A Case Report with Molecular Profile

20. Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

21. The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

22. Preexisting evidence and outcome of phase III trials in gastrointestinal oncology: a systematic review

23. The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study

24. Fortnightly or fractionated weekly docetaxel–cisplatin–5‐FU as first‐line treatment in advanced gastric and gastroesophageal junction adenocarcinoma: The randomized phase II DoGE study

25. Personalized selective internal radiation therapy in liver metastasis of thyroid cancer with impaired liver function: A case report

26. Retrospective analysis of the immunogenic effects of intra-arterial locoregional therapies in hepatocellular carcinoma: a rationale for combining selective internal radiation therapy (SIRT) and immunotherapy

28. Circulating DNA in the neoadjuvant setting of early stage colon cancer

29. The metabolic clinical risk score as a new prognostic model for surgical decision‐making in patients with colorectal liver metastases

30. First-Line Nivolumab Plus Low-Dose Ipilimumab for Microsatellite Instability-High/Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Phase II CheckMate 142 Study

31. Isotoxic high-dose stereotactic body radiotherapy integrated in a total multimodal neoadjuvant strategy for the treatment of localized pancreatic ductal adenocarcinoma

32. Buschke-Löwenstein tumor in a human immunodeficiency virus-positive patient: a case report and short literature review

33. Treatment compliance in early-stage anal cancer

34. Personalised radioembolization improves outcomes in refractory intra-hepatic cholangiocarcinoma: a multicenter study

35. CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial

36. Combined Metabolically Active Tumor Volume and Early Metabolic Response Improve Outcome Prediction in Metastatic Colorectal Cancer

37. Subgroup analyses of patients (pts) with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) plus low-dose ipilimumab (IPI) as first-line (1L) therapy:Two-year clinical update

38. Total neoadjuvant therapy for rectal cancer: Making sense of the results from the RAPIDO and PRODIGE 23 trials

39. 505TiP REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)

40. Clinico-metabolic characterization improves the prognostic value of histological growth patterns in patients undergoing surgery for colorectal liver metastases

41. Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer

42. Abstract CT192: Phase IIa open-label clinical study of intratumoural administration of BO-112 in combination with pembrolizumab in subjects with liver metastasis from colorectal cancer or gastric/gastro-oesophageal junction cancer

43. Association between the histopathological growth patterns of liver metastases and survival after hepatic surgery in breast cancer patients

44. Postoperative C-reactive protein kinetics predict postoperative complications in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis

45. Infiltrative tumour growth pattern correlates with poor outcome in oesophageal cancer

46. SO-27 Nivolumab plus low-dose ipilimumab in previously treated patients with microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: 4-year follow-up from CheckMate 142

47. P-276 Sex and regorafenib toxicity in refractory colorectal cancer: A safety analysis of the RegARd-C trial

48. Prognostic Value of the Pace of Tumor Progression as Assessed by Serial 18F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial

49. Novel strategies using modern radiotherapy to improve pancreatic cancer outcomes: toward a new standard?

50. The lack of selection criteria for surgery in patients with non-colorectal non-neuroendocrine liver metastases

Catalog

Books, media, physical & digital resources